Clinical Trials Insight: 700028885
Phase of Trial: Phase II
Latest Information Update: 14 May 2008
At a glance
- Drugs Auriclosene (Primary)
- Indications Staphylococcal infections
- Focus Therapeutic Use
- Sponsors NovaBay Pharmaceuticals
- 14 May 2008 Results expected to be announced in late May 2008.
- 14 May 2008 Status changed from initiated to completed, according to a NovaBay media release.
- 11 Mar 2008 Status changed from planning to initiated, from a NovaBay media release.